Your browser doesn't support javascript.
loading
Complement C3 identified as a unique risk factor for disease severity among young COVID-19 patients in Wuhan, China.
Cheng, Weiting; Hornung, Roman; Xu, Kai; Yang, Cai Hong; Li, Jian.
Afiliação
  • Cheng W; Oncology Department, Wuhan No.1 Hospital, Wuhan, 430022, China.
  • Hornung R; Institute of Medical Information Processing, Biometry and Epidemiology, Ludwig-Maximilian-University Munich, Munich, Germany.
  • Xu K; Department of Orthopedics, Tongji Hospital, Huazhong University of Science and Technology, Jiefang Avenue 1095, Wuhan, 430030, Province Hubei, China. godocoto@163.com.
  • Yang CH; Department of Orthopedics, Tongji Hospital, Huazhong University of Science and Technology, Jiefang Avenue 1095, Wuhan, 430030, Province Hubei, China.
  • Li J; Institute of Experimental Immunology, University Clinic of Rheinische Friedrich-Wilhelms-University, Bonn, Germany.
Sci Rep ; 11(1): 7857, 2021 04 12.
Article em En | MEDLINE | ID: mdl-33846344

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complemento C3 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complemento C3 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article